scholarly journals HIV Lipodystrophy

2020 ◽  
Author(s):  
Keyword(s):  
Hiv Lipodystrophy

Metabolic Effects of Rosiglitazone in HIV Lipodystrophy

2004 ◽  
Vol 140 (10) ◽  
pp. 786 ◽  
Author(s):  
Colleen Hadigan ◽  
Sigal Yawetz ◽  
Abraham Thomas ◽  
Fiona Havers ◽  
Paul E. Sax ◽  
...  
Keyword(s):  
Metabolic Effects ◽  
Hiv Lipodystrophy

scholarly journals Hiv-associated lipodystrophy and exercise

2006 ◽  
Vol 62 (2) ◽  
Author(s):  
E. Mutimura ◽  
A. Stewart ◽  
N. J. Crowther
Keyword(s):  
Health Care ◽  
Health Care Professionals ◽  
Sub Saharan Africa ◽  
Sufficient Evidence ◽  
Metabolic Dysfunction ◽  
Exercise Participation ◽  
Need To Evaluate ◽  
Sub Saharan ◽  
Hiv Lipodystrophy ◽  
Hiv Aids

As individuals affected by HIV/AIDS live longer due to the availability of HAART, the challenge to health care professionals is to manage and alleviate abnormalities associated with HAART. HIVlipodystrophy- altered body fat redistribution- is the most common stigmatising physical abnormality related to the use of HAART, which maybe alleviated by exercise participation. Currently, there is no reliable management standard care for HIV-associated lipodystrophy. However, there is sufficient evidence to support the benefits of exercise in adults with HIV infection. As various types of ARTs become available in the most HIV/AIDS stricken developing countries, there are inadequate studies to evaluate and promote exercise in alleviating HIV lipodystrophy and other related complications. The current paper reviews HIV-related lipodystrophy, related metabolic dysfunction, and the role of exercise in its management. The paper highlights the need to evaluate the effectiveness of exercise on HIV lipodystrophy syndrome. An emphasis needs to be put on raising awareness among health care professionals in Sub-Saharan Africa where the prevalence of HIV/AIDS is the  highest in the world.

scholarly journals Pathophysiology of Adipocyte Defects and Dyslipidemia in HIV Lipodystrophy: New Evidence from Metabolic and Molecular Studies

2006 ◽  
Vol 2 (3) ◽  
pp. 167-172 ◽  
Author(s):  
Ashok Balasubram ◽  
Rajagopal V. Sekhar ◽  
Farook Jahoor ◽  
Henry J. Pownall ◽  
Dorothy Lewis
Keyword(s):  
Molecular Studies ◽  
Hiv Lipodystrophy ◽  
New Evidence

Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy

2004 ◽  
Vol 286 (2) ◽  
pp. E261-E271 ◽  
Author(s):  
Julia A. Johnson ◽  
Jeanine B. Albu ◽  
Ellen S. Engelson ◽  
Susan K. Fried ◽  
Yoritaro Inada ◽  
...  
Keyword(s):  
Adipose Tissue ◽  
Highly Active Antiretroviral Therapy ◽  
Proinflammatory Cytokine ◽  
Whole Body ◽  
Metabolic Abnormalities ◽  
Lipodystrophy Syndrome ◽  
Highly Active ◽  
Tnf Α ◽  
Adipose Tissue Remodeling ◽  
Hiv Lipodystrophy

The lipodystrophy syndrome (adipose tissue redistribution and metabolic abnormalities) observed with highly active antiretroviral therapy (HAART) during human immunodeficiency virus (HIV) infection may be related to increased proinflammatory cytokine activity. We measured acute cytokine (TNF-α, IL-6, leptin), glycerol, and lactate secretion from abdominal subcutaneous adipose tissue (SAT), and systemic cytokine levels, in HIV-infected subjects with and without lipodystrophy (HIVL+ and HIVL–, respectively) and healthy non-HIV controls. Lipodystrophy was confirmed and characterized as adipose tissue redistribution in HIVL+ compared with HIVL– and controls, by dual-energy X-ray absorptiometry and by whole body MRI. TNF-α secretion from abdominal SAT and circulating levels of IL-6, soluble TNF receptors I and II, and insulin were elevated in HIVL+ relative to HIVL– and/or controls, particularly in HIVL+ undergoing HAART. In the HIV-infected group as a whole, IL-6 secretion from abdominal SAT and serum IL-6 were positively associated with visceral fat and were negatively associated with the relative amount of lower limb adipose tissue ( P < 0.01). Decreased leptin and increased lactate secretion from abdominal SAT were specifically associated with HAART. In conclusion, increased cytokine secretion from adipose tissue and increased systemic proinflammatory cytokine activity may play a significant role in the adipose tissue remodeling and/or the metabolic abnormalities associated with the HIV-lipodystrophy syndrome in patients undergoing HAART.

HIV-Associated Lipodystrophy and Lipoatrophy

2017 ◽  
Author(s):  
Rajagopal V. Sekhar
Keyword(s):  
Fat Distribution ◽  
Natural Evolution ◽  
Metabolic Complications ◽  
Body Habitus ◽  
Specific Effects ◽  
Hiv Virus ◽  
Antiretroviral Medications ◽  
Drug Regimens ◽  
Central Fat ◽  
Hiv Lipodystrophy

Patients with HIV have been seen to manifest unusual changes in body habitus that constitute variable combinations of peripheral fat loss ( lipoatrophy), central fat accumulation (lipohypertrophy), and the condition known as HIV-associated lipodystrophy (HAL). Although the origins of HAL are unclear, several factors have been linked to it. Because better antiretroviral therapy (ART) drug regimens have led to increased longevity, it is possible that the natural evolution of metabolic complications of HIV is the lipodystrophic phenotype. The specific effects of antiretroviral medications have also been implicated, and the initial usage of ART in the 1990s was accompanied by multiple reports of abnormalities in body fat distribution variously termed the “protease paunch,” “crixivan belly,” among others. Other factors include immune phenomenon and effects mediated directly by the HIV virus. Despite intensive research to understand the mechanistic underpinnings of HIV lipodystrophy and lipoatrophy, the answers remain elusive.

scholarly journals Short-term overfeeding increases resting energy expenditure in patients with HIV lipodystrophy

2007 ◽  
Vol 86 (4) ◽  
pp. 1009-1015 ◽  
Author(s):  
Lisa A Kosmiski ◽  
Daniel H Bessesen ◽  
Sarah A Stotz ◽  
John R Koeppe ◽  
Tracy J Horton
Keyword(s):  
Energy Expenditure ◽  
Resting Energy Expenditure ◽  
Short Term ◽  
Hiv Lipodystrophy ◽  
Resting Energy

HIV lipodystrophy

AIDS ◽  
2003 ◽  
Vol 17 ◽  
pp. S141-S148 ◽  
Author(s):  
Andrew Carr
Keyword(s):  
Hiv Lipodystrophy

scholarly journals A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy

HIV Medicine ◽  
2007 ◽  
Vol 8 (7) ◽  
pp. 420-426 ◽  
Author(s):  
R Kohli ◽  
A Shevitz ◽  
S Gorbach ◽  
C Wanke
Keyword(s):  
Controlled Trial ◽  
Hiv Lipodystrophy

Short-term energy restriction reduces resting energy expenditure in patients with HIV lipodystrophy and hypermetabolism

Metabolism ◽  
2007 ◽  
Vol 56 (2) ◽  
pp. 289-295 ◽  
Author(s):  
Lisa A. Kosmiski ◽  
Daniel H. Bessesen ◽  
Sarah A. Stotz ◽  
John R. Koeppe ◽  
Tracy J. Horton
Keyword(s):  
Energy Expenditure ◽  
Resting Energy Expenditure ◽  
Energy Restriction ◽  
Short Term ◽  
Term Energy ◽  
Hiv Lipodystrophy ◽  
Resting Energy
Sign in / Sign up

Export Citation Format

Share Document